157 related articles for article (PubMed ID: 10385050)
1. Clinical features and anti-neural reactivity in neuropathy associated with IgG monoclonal gammopathy of undetermined significance.
Di Troia A; Carpo M; Meucci N; Pellegrino C; Allaria S; Gemignani F; Marbini A; Mantegazza R; Sciolla R; Manfredini E; Scarlato G; Nobile-Orazio E
J Neurol Sci; 1999 Mar; 164(1):64-71. PubMed ID: 10385050
[TBL] [Abstract][Full Text] [Related]
2. Polyneuropathy associated with IgG/IgA monoclonal gammopathy: a clinical and electrophysiological study of 15 cases.
Magy L; Chassande B; Maisonobe T; Bouche P; Vallat JM; Léger JM
Eur J Neurol; 2003 Nov; 10(6):677-85. PubMed ID: 14641513
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic criteria for demyelinating polyneuropathy associated with monoclonal gammopathy.
Notermans NC; Franssen H; Eurelings M; Van der Graaf Y; Wokke JH
Muscle Nerve; 2000 Jan; 23(1):73-9. PubMed ID: 10590408
[TBL] [Abstract][Full Text] [Related]
4. Comparison of IgM-MGUS and IgG-MGUS polyneuropathy.
Simovic D; Gorson KC; Ropper AH
Acta Neurol Scand; 1998 Mar; 97(3):194-200. PubMed ID: 9531437
[TBL] [Abstract][Full Text] [Related]
5. [Neuropathy associated with dysglobulinemia and monoclonal gammopathy].
Saito T
Nihon Rinsho; 1994 Nov; 52(11):2976-83. PubMed ID: 7996697
[TBL] [Abstract][Full Text] [Related]
6. Chronic inflammatory demyelinating polyradiculoneuropathy: comparison of patients with and without an associated monoclonal gammopathy.
Bromberg MB; Feldman EL; Albers JW
Neurology; 1992 Jun; 42(6):1157-63. PubMed ID: 1603342
[TBL] [Abstract][Full Text] [Related]
7. Chronic inflammatory demyelinating polyneuropathy: clinical features and response to treatment in 67 consecutive patients with and without a monoclonal gammopathy.
Gorson KC; Allam G; Ropper AH
Neurology; 1997 Feb; 48(2):321-8. PubMed ID: 9040714
[TBL] [Abstract][Full Text] [Related]
8. Neuropathies associated with IgG and IgA monoclonal gammopathy.
Nobile-Orazio E; Casellato C; Di Troia A
Rev Neurol (Paris); 2002 Oct; 158(10 Pt 1):979-87. PubMed ID: 12407307
[TBL] [Abstract][Full Text] [Related]
9. Frequency and clinical correlates of anti-neural IgM antibodies in neuropathy associated with IgM monoclonal gammopathy.
Nobile-Orazio E; Manfredini E; Carpo M; Meucci N; Monaco S; Ferrari S; Bonetti B; Cavaletti G; Gemignani F; Durelli L
Ann Neurol; 1994 Sep; 36(3):416-24. PubMed ID: 8080249
[TBL] [Abstract][Full Text] [Related]
10. Polyneuropathy associated with monoclonal gammopathy of undetermined significance: further evidence that IgM-MGUS neuropathies are different than IgG-MGUS.
Suarez GA; Kelly JJ
Neurology; 1993 Jul; 43(7):1304-8. PubMed ID: 8327128
[TBL] [Abstract][Full Text] [Related]
11. Sural nerve T cells in demyelinating polyneuropathy associated with monoclonal gammopathy.
Eurelings M; Notermans NC; Wokke JH; Bosboom WM; Van den Berg LH
Acta Neuropathol; 2002 Feb; 103(2):107-14. PubMed ID: 11810175
[TBL] [Abstract][Full Text] [Related]
12. Characterizing neuropathies associated with monoclonal gammopathy of undetermined significance (MGUS): a framework consistent with classifying injuries according to fiber size.
Fisher MA; Wilson JR
Neurol Clin Neurophysiol; 2002; 2002(3):2-7. PubMed ID: 12028821
[TBL] [Abstract][Full Text] [Related]
13. Presentation and initial clinical course in patients with chronic inflammatory demyelinating polyradiculoneuropathy: comparison of patients without and with monoclonal gammopathy.
Simmons Z; Albers JW; Bromberg MB; Feldman EL
Neurology; 1993 Nov; 43(11):2202-9. PubMed ID: 8232929
[TBL] [Abstract][Full Text] [Related]
14. Antibodies to L-periaxin in sera of patients with peripheral neuropathy produce experimental sensory nerve conduction deficits.
Lawlor MW; Richards MP; De Vries GH; Fisher MA; Stubbs EB
J Neurochem; 2002 Nov; 83(3):592-600. PubMed ID: 12390521
[TBL] [Abstract][Full Text] [Related]
15. Clinical features, evaluation, and treatment of patients with polyneuropathy associated with monoclonal gammopathy of undetermined significance (MGUS).
Gorson KC
J Clin Apher; 1999; 14(3):149-53. PubMed ID: 10540371
[TBL] [Abstract][Full Text] [Related]
16. [Polyneuropathy associated with monoclonal gammapathy: treatment perspectives].
Leger JM; Chassande B; Bombelli F; Viala K; Musset L; Neil J
Bull Acad Natl Med; 2009 May; 193(5):1099-110; discussion 1110-1. PubMed ID: 20120390
[TBL] [Abstract][Full Text] [Related]
17. Peripheral neuropathy in monoclonal gammopathy of undetermined significance: prevalence and immunopathogenetic studies.
Nobile-Orazio E; Barbieri S; Baldini L; Marmiroli P; Carpo M; Premoselli S; Manfredini E; Scarlato G
Acta Neurol Scand; 1992 Jun; 85(6):383-90. PubMed ID: 1379409
[TBL] [Abstract][Full Text] [Related]
18. [Peripheral neuropathy with monoclonal gammopathy].
Meier T; Meyer M
Schweiz Med Wochenschr; 1990 Mar; 120(12):417-25. PubMed ID: 2157280
[TBL] [Abstract][Full Text] [Related]
19. [Clinical factors relating to the presence of serum anti-GM1 and GD1b antibodies in demyelinating neuropathy--study using a multivariate analysis].
Irie S; Saito T; Kanazawa N; Ito H; Kowa H
Rinsho Shinkeigaku; 1994 May; 34(5):454-60. PubMed ID: 7924057
[TBL] [Abstract][Full Text] [Related]
20. Polyneuropathy and monoclonal gammopathy of undetermined significance (MGUS); update of a clinical experience.
Matà S; Torricelli S; Barilaro A; Grippo A; Forleo P; Del Mastio M; Sorbi S
J Neurol Sci; 2021 Apr; 423():117335. PubMed ID: 33647732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
